CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-05 | EMSTER KURT VON Director | Purchase | +65,934 | $22.75 | $1.5M | 1,887,202 |
| 2018-01-05 | EMSTER KURT VON Director | Sale | −92,337 | $26.96 | $2.5M | 1,821,268 |
| 2018-01-02 | EMSTER KURT VON Director | Sale | −37,754 | $26.76 | $1.0M | 1,913,605 |
| 2018-01-02 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −30,000 | $20.55 | $617K | 70,204 |
| 2018-01-02 | Dylan-Hyde Tyler Chief Legal Officer | Option exercise | +8,000 | $12.57 | $101K | 78,204 |
| 2018-01-02 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −8,000 | $25.75 | $206K | 70,204 |
| 2018-01-02 | Dylan-Hyde Tyler Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −6,490 | 37,773 | ||
| 2018-01-02 | Dylan-Hyde Tyler Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −1,510 | 25,157 | ||
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Option exercise | +6,230 | $14.43 | $90K | 121,434 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −6,230 | $21.75 | $136K | 115,204 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Option exercise | +9,070 | $12.57 | $114K | 124,274 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −1,070 | $21.75 | $23K | 123,204 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −8,000 | $23.76 | $190K | 115,204 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −15,000 | $22.68 | $340K | 100,204 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −6,230 | 58,070 | ||
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −9,070 | 44,263 | ||
| 2017-12-28 | Dylan-Hyde Tyler Chief Legal Officer | Option exercise | +700 | $14.43 | $10K | 115,904 |
| 2017-12-28 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −700 | $21.75 | $15K | 115,204 |
| 2017-12-28 | Dylan-Hyde Tyler Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −700 | 64,300 | ||
| 2017-12-22 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −15,000 | $20.55 | $308K | 115,204 |
Page 56 of 62 · 1,221 trades